The conundrum of death, dying and organ donation

No abstract is available for this paper.

• Publication year

  2002

• Venue

  British Journal of Ophthalmology

• Publication date

  2002-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/bjo.86.9.992PMID 12185123PMCID PMC1771260
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The profile of repeated corneal transplantation.

  2001cited by this paper
• Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group.

  2000cited by this paper
• Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease1

  2000cited by this paper
• Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group.

  2000cited by this paper
• Efficacy and safety of cyclosporin a ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: A dose-ranging, randomized trial☆

  2000cited by this paper
• Local therapy of corneal allograft rejection with cyclosporine.

  1995cited by this paper
• Suppression of Corneal Allograft Rejection by Systemic Cyclosporine-A in Heavily Vascularized Rabbit Corneas Following Alkali Burns

  1994cited by this paper
• Topical Cyclosporin A in the Treatment of Anterior Segment Inflammatory Disease

  1993cited by this paper
• Pilot Trial of Cyclosporine 1% Ophthalmic Ointment in the Treatment of Keratoconjunctivitis Sicca

  1993cited by this paper
• The use of cyclosporine in high-risk keratoplasty.

  1989cited by this paper
• The use of cyclosporine in high-risk keratoplasty.

  1989cited by this paper
• Successful engraftment of high-risk corneal allografts with short-term immunosuppression with cyclosporine.

  1988cited by this paper
• AN ANIMAL MODEL FOR CORNEAL GRAFT REJECTION IN HIGH‐RISK KERATOPLASTY

  1988cited by this paper
• [Cyclosporin A eyedrops in the prevention of high-risk corneal graft rejection. II. Postoperative clinical results].

  1987cited by this paper
• Topical steroid, cyclosporin A, and the outcome of rat corneal allografts.

  1987cited by this paper
• Visual results in repeat penetrating keratoplasty.

  1986cited by this paper
• Cyclosporine: immunology, pharmacology and therapeutic uses.

  1986cited by this paper
• Cyclosporine eyedrops for the treatment of severe vernal keratoconjunctivitis.

  1986cited by this paper
• The use of systemic cyclosporin a in human corneal transplantation: a preliminary report

  1986cited by this paper
• [Local treatment of corneal transplants in the human with cyclosporin A].

  1985cited by this paper
• A comparison of the effects of topical cyclosporine and topical steroid on rabbit corneal allograft rejection.

  1985cited by this paper
• Effectiveness of cyclosporin therapy for Behçet's disease.

  1985cited by this paper
• Lokale Behandlung des Hornhauttransplantates beim Menschen mit Cyclosporin A

  1985cited by this paper
• Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents.

  1983cited by this paper
• Blood-pressure-lowering effect of a vegetarian diet: controlled trial in normotensive subjects.

  1983cited by this paper
• Cyclosporin A applied topically to the recipient eye inhibits corneal graft rejection.

  1981cited by this paper
• Indications, complications and prognosis for repeat penetrating keratoplasty.

  1979cited by this paper
• Prolonged survival of corneal allografts in rabbits treated with cyclosporin A.

  1979cited by this paper
• Indications, complications and prognosis for repeat penetrating keratoplasty.

  1979cited by this paper
• The Prognosis of Keratoplasty After Previous Graft Failures

  1974cited by this paper
• The prognosis of deratoplasty after previous graft failures.

  1974cited by this paper
• Suppression of a

  1969cited by this paper

• Influential Factors and Outcome of High-Risk Keratoplasty in a Tertiary Referral Corneal Center: A Retrospective Study

  2025cites this paper
• Topical tacrolimus for high-risk corneal transplantation: a randomized, clinical trial

  2024cites this paper
• NF-κB c-Rel Is a Potential Therapeutic Target for Acute Corneal Transplant Rejection

  2023cites this paper
• Roles of biomaterials in modulating the innate immune response in ocular therapy

  2023cites this paper
• Topical corticosteroids with topical cyclosporine A versus topical corticosteroids alone for immunological corneal graft rejection

  2021cites this paper
• Efficacy of Immunosuppressants in High Rejection Risk Keratoplasty: A Meta-Analysis of Comparative Studies

  2021cites this paper
• Variable Responses to Corneal Grafts: Insights from Immunology and Systems Biology

  2020cites this paper
• Demonstration of technical feasibility and viability of whole eye transplantation in a rodent model.

  2019cites this paper
• Systemic Immunomodulatory Strategies in High-risk Corneal Transplantation

  2017cites this paper
• Update on the Management of High-Risk Penetrating Keratoplasty

  2017cites this paper
• Management of high-risk corneal transplantation.

  2017cites this paper
• Improving the topical ocular pharmacokinetics of an immunosuppressant agent with mucoadhesive nanoemulsions: Formulation development, in-vitro and in-vivo studies.

  2016cites this paper
• Post-operative Management

  2016cites this paper
• Systemic cyclosporine and corneal transplantation

  2016cites this paper
• High-risk corneal allografts: A therapeutic challenge.

  2016cites this paper
• Systemic Immunosuppression in High-Risk Penetrating Keratoplasty: A Systematic Review

  2016influential citation
• Cyclosporine nanomicelle eye drop: a novel medication for corneal graft transplantation treatment.

  2015cites this paper
• Adverse effects of low-dose systemic cyclosporine therapy in high-risk penetrating keratoplasty

  2015cites this paper
• [Cyclosporine eye drops: A 4-year retrospective study (2009-2013)].

  2015cites this paper
• Tim-1 blockade with RMT1-10 increases T regulatory cells and prolongs the survival of high-risk corneal allografts in mice.

  2014cites this paper
• The Efficacy of Low-Dose Systemic Cyclosporine for Graft Failure after Penetrating Keratoplasty in High-Risk Group

  2014cites this paper
• Prevention and Treatment of Transplant Rejection in Keratoplasty

  2014cites this paper
• transplantation : a cohort study rejection in high-risk corneal Topical 0 . 03 % tacrolimus preventing

  2013cites this paper
• Clinical Transplantation of Individualized Recipient Serum-Adapted Cornea Reduces the Risk of Graft Rejection after Keratoplasty

  2013cites this paper
• Results of a phase I/II clinical trial: standardized, non-xenogenic, cultivated limbal stem cell transplantation

  2013cites this paper
• Topical 0.03% tacrolimus preventing rejection in high-risk corneal transplantation: a cohort study

  2013cites this paper
• Prevenção de rejeição em transplantes de córnea de alto risco com tacrolimus 0,03% colírio

  2013cites this paper
• Keratoplasty Postoperative Treatment Update

  2013cites this paper
• Ocular safety of cationic emulsion of cyclosporine in an in vitro corneal wound-healing model and an acute in vivo rabbit model

  2012cites this paper
• Clinical outcomes of penetrating keratoplasty after autologous cultivated limbal epithelial transplantation for ocular surface burns.

  2011cites this paper
• Ocular Surface Reconstitution

  2011cites this paper
• Le rejet d’allogreffe de cornée

  2011cites this paper
• Immunologically High-Risk Penetrating Keratoplasty

  2011cites this paper
• [Rejection of corneal allografts].

  2011cites this paper
• Influence of combined treatment of low dose rapamycin and cyclosporin A on corneal allograft survival

  2010cites this paper
• Management of Corneal Graft Rejection - A Case Series Report and Review of the Literature.

  2010cites this paper
• Establishment of a murine model of chronic corneal allograft dysfunction

  2010cites this paper
• Thiolated nanostructured lipid carriers as a potential ocular drug delivery system for cyclosporine A: Improving in vivo ocular distribution.

  2010cites this paper
• Sirolimus and mycophenolate as combination prophylaxis in corneal transplant recipients at high rejection risk.

  2010cites this paper
• Update on Immunosuppressive Therapy for Corneal Transplantation

  2010cites this paper
• Mechanisms of corneal allograft rejection and the development of new therapies

  2010cites this paper
• Hipertensión ocular postqueratoplastía

  2010cites this paper
• [Advantages and limits of multiple grafts (third keratoplasty) under local cyclosporin 2%].

  2010cites this paper
• Corneal Graft Rejection: A Review Of Literature And Recent Advances

  2010cites this paper
• Hyaluronic acid coated poly-epsilon-caprolactone nanospheres deliver high concentrations of cyclosporine A into the cornea.

  2008cites this paper
• Uses and safety profile of ciclosporin in ophthalmology

  2008cites this paper
• Prolongation of Corneal Allograft Survival by Topical Application of Everolimus in Experimental Keratoplasty

  2008cites this paper
• Prolongation of corneal xenotransplant survival by T‐cell vaccination‐induced T‐regulatory cells

  2008cites this paper
• Evaluation of topical ciclosporin 0.05% for prevention of rejection in high-risk corneal grafts

  2008cites this paper
• Ocular surface reconstruction: recent innovations, surgical candidate selection and postoperative management

  2008cites this paper
• Uses and safety profile of ciclosporin in ophthalmology.

  2008cites this paper
• Corneal graft rejection.

  2007cites this paper
• The Immunobiology of Corneal Transplantation

  2007cites this paper
• Penetrating keratoplasty in a California Brown Pelican.

  2007cites this paper
• Phenotypic study after cultivated limbal epithelial transplantation for limbal stem cell deficiency.

  2007cites this paper
• Current Aspects of the Immunobiology and Prevention of Corneal Graft Rejection: What Have We Learned from 100 Years of Keratoplasty?

  2007cites this paper
• Tacrolimus immunosuppression in high-risk corneal grafts

  2006cites this paper
• Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats.

  2006cites this paper
• Prospective, randomized study of the efficacy of systemic cyclosporine in high-risk corneal transplantation.

  2006cites this paper
• Immunosuppressive agents and nonsteroidal anti-inflammatory drugs for ocular immune and inflammatory disorders.

  2005cites this paper
• The impact of corneal allograft rejection on the long-term outcome of corneal transplantation.

  2005cites this paper
• Early results of penetrating keratoplasty after cultivated limbal epithelium transplantation.

  2005cites this paper
• Trasplante de córnea: Criterio clínico quirúrgico

  2005cites this paper
• Immunomodulation for corneal transplantation

  2005cites this paper
• Gene therapy approaches to prolonging corneal allograft survival

  2004cites this paper
• Aus der Augenklinik und Poliklinik der Ludwig-Maximilians-Universität München

  2004cites this paper
• Préparation d’un collyre de ciclosporine à 2 %

  2004cites this paper
• [Cyclosporine 2% eye drops preparation].

  2004cites this paper
• Immunmodulation bei perforierender Keratoplastik

  2003cites this paper
• [Immunomodulation in penetrating keratoplasty. Current status and perspectives].

  2003cites this paper
• Development and progression of cataract in patients required repeated corneal transplantation

  2003cites this paper